Lilly cancer drug with accelerated approval fails in confirmatory trial
A Phase III trial of Lartruvo, which won accelerated approval for soft-tissue sarcoma in 2016, failed to confirm an overall survival benefit.
A Phase III trial of Lartruvo, which won accelerated approval for soft-tissue sarcoma in 2016, failed to confirm an overall survival benefit.
Fully incorporating value into pricing will require significant effort and investment, the Novartis CEO said. Meanwhile, CVS/Caremark's Larry Merlo said the company's acquisition of Aetna opened opportunities for innovative pricing models.
CEO David Ricks advocates careful approach focused on differentiation of assets in breakout session, while CFO says company has capacity for one transaction per quarter.
Loxo's shares were up 65 percent on the news. The company won FDA accelerated approval on Nov. 26 for its tissue-agnostic cancer drug, Vitrakvi.
Memorial Sloan Kettering Chief Medical Officer Jose Baselga resigned Thursday following publication of a New York Times-ProPublica investigation of his financial relationships with drugmakers.
Gerald "Jerry" Matczak of Eli Lilly & Co. was a rare breed in the pharmaceutical world, someone who not only embraced social media, but also listened to activist patients.
A specialty drug is a class of prescription medications used to treat complex, chronic or rare medical conditions. Although this classification was originally intended to define the treatment of rare, also termed “orphan” diseases, affecting fewer than 200,000 people in the US, more recently, specialty drugs have emerged as the cornerstone of treatment for chronic and complex diseases such as cancer, autoimmune conditions, diabetes, hepatitis C, and HIV/AIDS.
At least four healthcare executives have either resigned, been fired or taken on a lesser role since the first of the year — and the head of NIH may be out soon, too.
Also, Avik Roy jumps on board with Marco Rubio, learn how much more patients trust providers over payers, and a new report on drug pricing in the United States versus Britain.